New Dopamine Receptor Stimulant Drug

Cellular and Molecular Life Sciences - Switzerland
doi 10.1007/bf01923149
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Correction To: Dopamine D1 Receptor Antagonist Reduces Stimulant-Induced Conditioned Place Preferences and Dopamine Receptor Supersensitivity

Naunyn-Schmiedeberg's Archives of Pharmacology
MedicinePharmacology
2019English

Dopamine Receptor Antagonism by the Novel Antianxiety Drug, Buspirone

Journal of Neuroscience
Neuroscience
1983English

Dopamine Receptor D4 Promoter Hypermethylation Increases the Risk of Drug Addiction

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

Dopamine Effects of Stimulant and Non-Stimulant Drugs Used in the Treatment of Attention Deficit Hyperactivity Disorder

English

Recent Methods for Measuring Dopamine D3 Receptor Occupancy in Vivo: Importance for Drug Development

Frontiers in Pharmacology
Pharmacology
2014English

Dopamine Receptor Heteromers: Biasing Antipsychotics

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2018English

Acute Dopamine Receptor Blockade in Substantia Nigra Pars Reticulata: A Possible Model for Drug Induced Parkinsonism

Journal of Neurophysiology
NeurosciencePhysiology
2018English

Synthetic Cathinone Analogues Structurally Related to the Central Stimulant Methylphenidate as Dopamine Reuptake Inhibitors

English

Analysis of Dopamine Receptor and Dopamine Transporter Genes in Schizophrenia

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy